Rare sugars and enzymatic sweeteners

01Overview and value chain

Markers: [EC: FDA allulose caloric/labeling exemption | OECD: Food systems | Regulator: FDA (USA), EFSA (EU)]

Rare sugars and enzymatic sweeteners use engineered enzymes — epimerases in particular — to convert commodity fructose or starch into low-calorie monosaccharides such as allulose (D-psicose) and tagatose that occur naturally in small quantities but taste and behave like ordinary sugar. Ingredion holds a patent describing epimerase-based conversion of fructose to allulose, and organic allulose has reportedly “crossed the line from industry legend to commercial reality” as a clean-label, reduced-sugar formulation ingredient. Bonumose produces high-volume, naturally occurring monosaccharides from commodity starch and sugar feedstocks using innovative enzyme combinations, and partnered with protein-engineering firm Allozymes in 2025 to accelerate new enzyme development. A parallel, non-sugar sweetener route uses fermentation rather than enzymatic conversion: Tate & Lyle and Manus Bio launched Yume, a stevia-derived sweetener brand, as allulose and tagatose gain prominence alongside it in the broader better-tasting, healthier-sweetener market.

Key directions of rare sugars and enzymatic sweeteners:

1. Enzymatic epimerization of commodity sugars (Enzymatic Epimerization of Commodity Sugars): epimerase enzymes convert abundant fructose into rare sugars like allulose without a full fermentation process.
2. High-volume rare-monosaccharide production (High-Volume Rare- Monosaccharide Production): enzyme-combination processes converting starch/sugar feedstocks into naturally occurring monosaccharides at commercial scale rather than trace extraction.
3. Fermentation-derived non-sugar sweeteners (Fermentation-Derived Non-Sugar Sweeteners): stevia-derived or other non-sugar sweetener molecules produced via precision fermentation as a complementary category to enzymatic rare sugars.
4. Clean-label reduced-sugar reformulation (Clean-Label Reduced-Sugar Reformulation): food brands reformulating existing sugar-sweetened products around allulose/tagatose to cut caloric sugar while keeping a clean ingredient label.

Sectoral value chain

[feedstock sourcing] ──> [enzyme engineering] ──> [enzymatic conversion] ──> [purification]
                                                          │
                                                  (regulatory
                                                   labeling status)
                                                          │
                                                          ▼
[food/beverage reformulation] <─── [ingredient sale] <───┘

Value chain levels

Cross-cutting technologies of the sector:

• Epimerase enzyme engineering (Epimerase Enzyme Engineering): protein-engineering partnerships developing improved epimerase variants for higher-yield sugar conversion.
• Enzyme-combination process design (Enzyme-Combination Process Design): multi-enzyme cascades converting commodity feedstocks to rare sugars at industrial volume.
• Regulatory caloric/labeling classification (Regulatory Caloric/Labeling Classification): securing a favorable calorie-count and labeling classification for a naturally occurring but rare sugar.

02US

The US hosts an enzyme-engineering rare-sugar originator and the ingredient giant holding a core epimerization patent.

enzyme-engineering partnerships, epimerase patents, commercial-reality allulose reformulation

• Bonumose: produces high-volume, naturally occurring monosaccharides from commodity starch and sugar using innovative enzyme combinations, and partnered with Allozymes in 2025 to accelerate enzyme innovation.
• Ingredion: holds a patent on epimerase-based fructose-to-allulose conversion, positioning it among the core enzymatic-conversion IP holders in the category.

03CN

Public information on a dedicated Chinese rare-sugar/enzymatic-sweetener originator at the scale of the US/EU leaders was not confirmed in this pass; the section stays at the policy level.

no confirmed flagship originator, regional distribution channels, adjacent ingredient trade activity

• No confirmed flagship originator: neither of the two East Asian candidates investigated in this pass returned a source directly confirming a rare-sugar/enzymatic-sweetener production program.
• Regional distribution activity: bulk allulose supply listings circulate through Chinese ingredient-trading platforms, reflecting active regional trade in the ingredient without a confirmed domestic originator.
• Adjacent academic research: metabolic-engineering research on allulose production (e.g., via Corynebacterium glutamicum) is active in the wider literature, ahead of a confirmed commercial-scale originator in this specific pass.

04EU

The UK-headquartered ingredient major anchors the region’s rare-sugar and adjacent fermentation-sweetener activity.

stevia-derived sweetener brand launch, allulose/tagatose market growth, clean-label reformulation demand

• Tate & Lyle: launched Yume, a stevia-derived sweetener brand, in partnership with fermentation specialist Manus Bio, alongside broader market growth in allulose and tagatose as consumers seek healthier, better-tasting sweeteners.
• Market-growth signal: industry data cited in trade coverage identifies allulose and tagatose as gaining prominence specifically because they combine health positioning with genuine sugar-like taste, unlike many earlier sugar substitutes.

05Leading companies and research institutes

06Tech stack and innovations

The stack converts abundant commodity sugars into rare, low-calorie equivalents at industrial volume.

1. Epimerase-driven fructose conversion (Epimerase-Driven Fructose Conversion):
   • epimerase enzymes rearrange fructose’s molecular structure into allulose, a rare sugar occurring only in trace amounts in nature.
   • case: Ingredion’s patented process describes exactly this epimerase-based fructose-to-allulose conversion route.
2. Multi-enzyme combination cascades (Multi-Enzyme Combination Cascades):
   • combinations of enzymes convert starch or sugar feedstocks into naturally occurring monosaccharides at high volume rather than trace extraction.
   • case: Bonumose’s enzyme-combination process is the basis of its high-volume rare-monosaccharide production.
3. Fermentation-based non-sugar sweetener production (Fermentation-Based Non-Sugar Sweetener Production):
   • a host organism is engineered to produce a non-sugar sweetener molecule (e.g., a stevia glycoside) via fermentation rather than enzymatic sugar conversion.
   • case: Manus Bio’s fermentation platform underlies the Yume stevia-derived sweetener brand launched with Tate & Lyle.

07Value chains and production pipelines

Industrial pipeline of an enzymatically converted rare sugar (FDA labeling classification)

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Feedstock sourcing     │ ───> │ 2. Enzyme engineering     │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Regulatory labeling review│ <─── │ 3. Enzymatic conversion & purification│
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Ingredient sale        │ ───> │ 6. Product reformulation  │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Feedstock sourcing

Commodity starch or fructose syrup is procured as the conversion substrate.

Stage 2: Enzyme engineering

Epimerase or other conversion enzymes are developed or licensed, sometimes through a dedicated protein-engineering partnership.

Stage 3: Enzymatic conversion & purification

The feedstock is converted into the target rare sugar and purified to a food-grade ingredient.

Stage 4: Regulatory labeling review

The rare sugar’s caloric-count and labeling classification is confirmed with FDA or EFSA before ingredient sale.

Stage 5: Ingredient sale

The purified rare sugar or fermentation-derived sweetener is sold to food and beverage manufacturers.

Stage 6: Product reformulation

Brands reformulate existing sugar-sweetened products around the new ingredient, cutting caloric sugar while keeping a clean label.